Publikationer från Endokrin tumörbiologi
Här visas de 50 senaste publikationerna från forskargruppen Endokrin tumörbiologi.
-
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis
Ingår i Endocrine, s. 171-179, 2023.
Artikel i tidskrift
-
Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
Ingår i World Journal of Surgery, s. 340-347, 2023.
Artikel i tidskrift
DOI för Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation Ladda ner fulltext (pdf) av Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
-
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
Ingår i Journal of neuroendocrinology, 2022.
Artikel i tidskrift
DOI för ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours Ladda ner fulltext (pdf) av ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
-
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
Ingår i Neuroendocrinology, s. 298-309, 2022.
Artikel i tidskrift
DOI för Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study Ladda ner fulltext (pdf) av Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
-
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
Ingår i Annals of Surgery Open, 2022.
Artikel i tidskrift
DOI för Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study Ladda ner fulltext (pdf) av Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
-
Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
Ingår i Endocrine Connections, 2022.
Artikel i tidskrift
DOI för Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors Ladda ner fulltext (pdf) av Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
-
A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
Ingår i Journal of Clinical Medicine, 2022.
Artikel i tidskrift
DOI för A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires Ladda ner fulltext (pdf) av A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
-
Targeted Therapies in Pheochromocytoma and Paraganglioma
Ingår i Journal of Clinical Endocrinology and Metabolism, s. 2963-2972, 2022.
Artikel, forskningsöversikt
DOI för Targeted Therapies in Pheochromocytoma and Paraganglioma
-
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Ingår i European Journal of Cancer, s. 56-73, 2021.
Artikel, forskningsöversikt
DOI för Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
-
Cardiac Imaging in Carcinoid Heart Disease
Ingår i JACC Cardiovascular Imaging, s. 2240-2253, 2021.
Artikel i tidskrift
-
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma
Ingår i European Journal of Endocrinology, s. R51-R59, 2021.
Artikel, forskningsöversikt
DOI för ENSAT registry-based randomized clinical trials for adrenocortical carcinoma
-
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours
Ingår i Current Treatment Options in Oncology, 2021.
Artikel, forskningsöversikt
DOI för Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours
-
Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability
Ingår i Neuroendocrinology, s. 831-839, 2021.
Artikel i tidskrift
-
177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
Ingår i Neuroendocrinology, s. 330-343, 2021.
Artikel i tidskrift
DOI för 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants Ladda ner fulltext (pdf) av 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
-
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma
Ingår i Clinical Cancer Research, s. 2989-2995, 2021.
Artikel i tidskrift
-
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment
Ingår i World Journal of Gastroenterology, s. 976-989, 2021.
Artikel i tidskrift
-
MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
Ingår i Scientific Reports, 2021.
Artikel i tidskrift
DOI för MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines Ladda ner fulltext (pdf) av MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
-
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
Ingår i Annals of Oncology, s. 1425-1433, 2021.
Artikel i tidskrift
-
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
Ingår i Annals of Surgical Oncology, s. 7506-7517, 2021.
Artikel i tidskrift
-
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
Ingår i Current Treatment Options in Oncology, 2021.
Artikel, forskningsöversikt
DOI för Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma Ladda ner fulltext (pdf) av Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
-
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement
Ingår i Neuroendocrinology, s. 609-630, 2021.
Artikel, forskningsöversikt
-
18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand
Ingår i European Journal of Pharmaceutical Sciences, 2021.
Artikel i tidskrift
DOI för 18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand
-
Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.
Ingår i Endocrine Connections, s. 422-431, 2021.
Artikel i tidskrift
DOI för Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE. Ladda ner fulltext (pdf) av Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.
-
Para-chloro-2-[18F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging
Ingår i International Journal of Medical Sciences, s. 2187-2196, 2021.
Artikel i tidskrift
DOI för Para-chloro-2-[18F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging Ladda ner fulltext (pdf) av Para-chloro-2-[18F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging
-
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
Ingår i Journal of Nuclear Medicine, s. 1712-1718, 2021.
Artikel i tidskrift
DOI för Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE Ladda ner fulltext (pdf) av Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
-
Whole genome sequencing of apparently mutation-negative MEN1 patients
Ingår i European Journal of Endocrinology, s. 35-45, 2020.
Artikel i tidskrift
DOI för Whole genome sequencing of apparently mutation-negative MEN1 patients
-
High-grade progression confers poor survival in pancreatic neuroendocrine tumors
Ingår i Neuroendocrinology, s. 891-898, 2020.
Artikel i tidskrift
DOI för High-grade progression confers poor survival in pancreatic neuroendocrine tumors
-
Neuroendocrine Neoplasms of the Small Bowel and Pancreas
Ingår i Neuroendocrinology, s. 444-476, 2020.
Artikel i tidskrift
DOI för Neuroendocrine Neoplasms of the Small Bowel and Pancreas
-
Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker
Ingår i International Journal of Cancer, s. 2326-2335, 2020.
Artikel i tidskrift
-
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Ingår i Journal of Hypertension, s. 1443-1456, 2020.
Artikel i tidskrift
-
An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis
Ingår i Neuroendocrinology, s. 198-216, 2020.
Artikel, forskningsöversikt
-
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Ingår i Advances in Medical Sciences, s. 18-29, 2020.
Artikel, forskningsöversikt
DOI för The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors Ladda ner fulltext (pdf) av The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
-
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms
Ingår i Neuroendocrinology, s. 185-197, 2020.
Artikel i tidskrift
-
Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line
Ingår i Scientific Reports, 2020.
Artikel i tidskrift
DOI för Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line Ladda ner fulltext (pdf) av Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line
-
Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
Ingår i Journal of Pathology, s. 183-194, 2020.
Artikel i tidskrift
-
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ingår i Annals of Oncology, s. 844-860, 2020.
Artikel i tidskrift
-
Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients
Ingår i Frontiers in Oncology, 2020.
Artikel i tidskrift
DOI för Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients Ladda ner fulltext (pdf) av Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients
-
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
Ingår i EJNMMI Physics, 2020.
Artikel i tidskrift
DOI för Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points Ladda ner fulltext (pdf) av Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
-
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 2372-2382, 2020.
Artikel i tidskrift
DOI för Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study Ladda ner fulltext (pdf) av Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study
-
Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.
Ingår i Upsala Journal of Medical Sciences, s. 325-329, 2020.
Artikel i tidskrift
-
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Ingår i The Oncologist, s. E662-E670, 2019.
Artikel i tidskrift
-
Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments
Ingår i Molecular Genetics & Genomic Medicine, 2019.
Artikel i tidskrift
DOI för Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments Ladda ner fulltext (pdf) av Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments
-
Adrenocortical carcinoma: towards genomics guided clinical care
Ingår i Nature Reviews Endocrinology, s. 548-560, 2019.
Artikel, forskningsöversikt
DOI för Adrenocortical carcinoma: towards genomics guided clinical care
-
Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis
Ingår i Endocrine-Related Cancer, s. 539-550, 2019.
Artikel, forskningsöversikt
-
Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms
Ingår i Endocrine, s. 384-392, 2019.
Artikel i tidskrift
DOI för Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms Ladda ner fulltext (pdf) av Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms
-
Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma
Ingår i Endocrine pathology, s. 173-179, 2019.
Artikel i tidskrift
DOI för Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma Ladda ner fulltext (pdf) av Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma
-
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
Ingår i JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019.
Artikel i tidskrift
DOI för Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome Ladda ner fulltext (pdf) av Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
-
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study
Ingår i The Oncologist, s. E1082-E1090, 2019.
Artikel i tidskrift
-
Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study
Ingår i Clinical Cancer Research, s. 6692-6699, 2019.
Artikel i tidskrift
-
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
Ingår i Endocrine Connections, s. 442-453, 2019.
Artikel i tidskrift
DOI för NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging Ladda ner fulltext (pdf) av NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging